Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amgen    AMGN

AMGEN (AMGN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about AMGEN
05:20pUCB : and Amgen Resubmit Biologics Licence Application for EVENITYTM to the U.S...
AQ
07/13AMGEN : And UCB Resubmit Biologics License Application (BLA) For EVENITY™ ..
PR
07/06DR REDDY LABORATORIES : Amgen - Dr. Reddy's announces the launch of Repatha in I..
AQ
07/04AMGEN : and Novartis Present New Data Demonstrating Long-Term Efficacy, Safety a..
AQ
07/04AMGEN : and MBC Biolabs Announce Winners of the Amgen Golden Ticket
AQ
07/02AMGEN : and Health and Benefits Consultant Piper Jordan Partner on First Migrain..
AQ
07/02AMGEN : Announces Top-Line Results from Phase 3 Study of ABP 710, Biosimilar Can..
AQ
06/29AMGEN : and MBC Biolabs Announce Winners of the Amgen Golden Ticket
PU
06/28AMGEN : And Novartis Present New Data Demonstrating Long-Term Efficacy, Safety A..
PU
06/28Mylan to Commercialize Lupin Ltd.'s Enbrel Biosimilar
DJ
06/27AMGEN : And Health And Benefits Consultant Piper Jordan Partner On First Migrain..
PU
06/27AMGEN : And Novartis Highlight Findings From A Large Global Patient Survey Revea..
PU
06/27AMGEN : to Seek Regulatory Approval for Biosimilar to J&J's Remicade
DJ
06/27AMGEN : Announces Top-Line Results From Phase 3 Study Of ABP 710, Biosimilar Can..
PU
06/27AMGEN : New Data Show Amgen's Repatha Significantly Reduced LDL-C and Non-HDL-C ..
AQ
More most relevant news
All news about AMGEN
05:20pUCB : and Amgen Resubmit Biologics Licence Application for EVENITYTM to the U.S...
AQ
07/16AMGEN : The National Academy of Sciences (NAS) - Workshop
AQ
07/14AMGEN : UCB and Amgen Resubmit Biologics Licence Application (BLA) for EVENITYTM..
AQ
07/14AMGEN : EVENITY Biologics License Application resubmitted for osteoporosis
AQ
07/13AMGEN : The National Academy of Sciences (NAS) - Workshop
AQ
07/13AMGEN : And UCB Resubmit Biologics License Application (BLA) For EVENITY™ ..
PR
07/12AMGEN : Study Results from Amgen Provide New Insights into Information Technolog..
AQ
07/09TODAY'S RESEARCH REPORTS ON STOCKS T : Biogen and Amgen
AC
07/06DR REDDY LABORATORIES : Amgen - Dr. Reddy's announces the launch of Repatha in I..
AQ
07/05AMGEN : Findings from Amgen in Monoclonal Antibodies Reported (Clinical Pharmaco..
AQ
More news
Sector news : Pharmaceuticals - NEC
06:31pJOHNSON & JOHNSON : J&J beats quarterly expectations on drug sales surge, shares..
RE
06:30pJOHNSON & JOHNSON : Pharma Business Fuels Sales Growth -- Update
DJ
05:56pJohnson & Johnson on Track for Largest Intraday Percent Increase Since Jan 20..
DJ
03:30pABBVIE : Signs Humira Patent License with Mylan
DJ
02:16pJOHNSON & JOHNSON : Pharmaceuticals Business Delivers, but Company Lowers Sales ..
DJ
09:05aInvestor 2Q Net Profit Rises 34%
DJ
More sector news : Pharmaceuticals - NEC
Official Publications
04/261st quarter results 
02/014th quarter results 
02/01SEC Filing 8K 
2017SEC Filing 10K 
20173rd quarter results 
2017Dividends 
More official Publications
News from SeekingAlpha
08:28aAbbVie out-licenses Humira patents to Mylan, biosimilar sales five years away.. 
07/16CVS responds to Trump Administration's request for info on now to lower drug .. 
07/16ALLERGAN : Crucial Period Ahead For Company As Activist Pressure Mounts 
07/16YOUR DAILY PHARMA SCOOP : Advaxis Trial Cleared, Atossa Trial Proceeds, Amgen Re.. 
07/16BIOTECH ANALYSIS CENTRAL PHARMA NEWS : Celgene's Protocol Change, Roche's BLA Fo.. 
07/143 THINGS IN BIOTECH, JULY 14 : Spiking Some Good News 
Latest Tweets
02:41pCould Amgen soften the Neulasta biosimilar blow with an Alexion buy?: Amgen i.. 
02:28pAbbVie out-licenses Humira patents to Mylan, biosimilar sales five years away..
3
02:09pLeerink Swann Comments on Amgen, Inc.’s Q2 2018 Earnings $AMGN  
01:29pLeerink Swann Lowers Amgen Q2 2018 Earnings Estimates to $3.51 EPS (Previousl.. 
12:57pAmgen $AMGN Given a $200.00 Price Target at Jefferies Financial Group  
More tweets
Qtime:204
Financials ($)
Sales 2018 22 583 M
EBIT 2018 11 632 M
Net income 2018 8 740 M
Finance 2018 10 236 M
Yield 2018 2,67%
P/E ratio 2018 15,49
P/E ratio 2019 14,77
EV / Sales 2018 5,29x
EV / Sales 2019 5,22x
Capitalization 130 B
Chart AMGEN
Duration : Period :
Amgen Technical Analysis Chart | AMGN | US0311621009 | 4-Traders
Technical analysis trends AMGEN
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 196 $
Spread / Average Target 0,47%
EPS Revisions
Managers
NameTitle
Robert A. Bradway Chairman & Chief Executive Officer
Esteban Santos Executive Vice President-Operations
David W. Meline CFO, Chief Accounting Officer & Executive VP
Frank C. Herringer Independent Director
Rebecca M. Henderson Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
AMGEN12.66%129 635
JOHNSON & JOHNSON-9.87%337 763
PFIZER3.62%219 534
NOVARTIS-4.54%201 464
ROCHE HOLDING LTD.-5.78%201 132
MERCK AND COMPANY11.23%169 193